Skip to content

A Cohort Study to Evaluate the Efficacy and Safety of Wechat Using in Intervening Neck Pain by Yijinjing

A Cohort Study to Evaluate the Efficacy and Safety of Wechat Using in Intervening Neck Pain by Yijinjing

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-13003426
Enrollment
Unknown
Registered
2013-08-06
Start date
2013-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical spondylosis

Interventions

1:Yijinjing Guided by Wechat
2:Yjinjng staying active without specific guide

Sponsors

Wanggang Community Medical Service Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Corresponding to diagnostic standards of cervical spondylosis; 2. Patients with chief complaint of neck pain; 3. One or more neck pain, neck stiffness attack on average per month for at least 3 months; 4. VAS scores more than 3 points at entry; 5. The result of antero-posterior and lateral radiogragh corresponds to x-ray diagnostic standards of cervical spondylosis, or MR/CT scan shows the degeneration of cervical spine or cervical disc heniation; 6. Age between 18~60 years; 7. Understanding and being willing to sigh the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Corresponding to the diagnostic standards of cervical spondylosis myelopathy; 2. Suffering from severe systemic diseases such as diabetes mellitus,cardio-cerebrovescular disease, tumors,and diseases that researchers consider unsuitable for research; 3. Having neck trauma/fracture/surgery history, neurologic impairment (such as myasthenia or abnormal spinal nerve reflex), congenital spinal abnormality, systemic diseases of bones or joints; 4. Pregnant or lactation period women; 5. Have taken acupuncture treatments of cervical spondylosis in the latest 3 months; 6. Receiving current treatments for cervical spondylosis(medicine or non-medicine).

Design outcomes

Primary

MeasureTime frame
SF-36;Tanaka Yasuku Cervical spondylosis symptom 20 scale;Pain VAS;

Countries

China

Contacts

Public ContactXiaoting Tang
tang.xiaoting@hotmail.com+86 13764446228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026